Usefulness of the new SOBIstat-F® device in children with severe acute asthma attacks in the Emergency Department: A randomized clinical trial.
Bibliographic record
Abstract
Background: Current protocols for the management of severe asthma exacerbations include step therapy with bronchodilators (short-acting beta 2-agonists, and ipratropium bromide) administered by nebulizer or meter doses inhaler (MDI) with a valved holding chamber, corticosteroids, and magnesium sulfate EV. This study aims to evaluate the effectiveness of a new device (SOBIstat-F ® ) for bronchodilator administration via MDI compared to the conventional method. Methods: A randomized clinical trial was conducted in children with severe acute asthma seen in two pediatric emergency departments. Patients were assigned to one of the following groups: MDI-SOBx in which they received bronchodilators in MDI through the SOBIstat-F® device, or in MDI with oxygen via cannula or mask (MDI-OxStand). The main outcome was the need for hospitalization at the end of 8 hours of treatment. Results: 84 patients participated in the study, of which 43 were treated with the MDI-SOBx device and 41 with MDI-OxStand. There were no differences in demographic characteristics or severity of the exacerbations between the groups. Those children treated with MDI-SOBx had a lower hospitalization rate versus those with the MDI-OxStand (9.3% vs. 26.8%, respectively, p=0.036). Also, a significant clinical improvement (pulmonary score) was observed from 90 minutes (p<0.001) and oxygen saturation from 60 min (p<0.001) in children in the MDI-SOBx group. Side effects were similar. Conclusions: The administration of bronchodilators using the SOBIstat-F ® device demonstrated, for the first time, to be more effective than the conventional method in reducing hospitalizations and in the clinical improvement of children with severe asthma exacerbations.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.003 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.004 | 0.002 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.002 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.003 | 0.003 |
| Insufficient payload (model declined to judge) | 0.005 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".